The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Pharmacological interactions of TKIs with the P-gp drug transport protein.
Sandra Roche
No relevant relationships to disclose
Kasper Pedersen
No relevant relationships to disclose
Grainne Dunne
No relevant relationships to disclose
Denis Collins
No relevant relationships to disclose
Aoife Devery
No relevant relationships to disclose
John Crown
Honoraria - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Martin Clynes
No relevant relationships to disclose
Robert O'Connor
No relevant relationships to disclose